In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Leadership

Set Alert for Leadership

Clinicians: ‘Show Me The Impact And Outcomes Of AI Tools’

Royal Philips’ ninth annual Future Health Index global report reveals a growing acceptance by clinicians and health care stakeholders of virtual care and AI-enabled innovation. These tools can address workforce shortages, financial burdens and growing demand for care, said chief innovation and strategy officer Shez Partovi.

Leadership Artificial Intelligence

Executives On The Move: May 2024

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Leadership Executive Changes

AI-Driven CHARM’s Number One Goal: Transitioning To A Clinical-Stage Biotech

Laksh Aithani, CEO of CHARM Therapeutics, discusses key challenges for the flourishing AI drug development sector including finding the right people and the need for more success stories.

Rising Leaders Clinical Trials

Execs On The Move: April 2024

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Leadership Executive Changes

Agnė Vaitkevičienė: The Versatile CEO Driving Memel Biotech

Rising star Agnė Vaitkevičienė is juggling roles as the CEO of an emerging Lithuanian biotech, with work for a partner company, the national biotech trade association and much more. 

Manufacturing Regenerative Medicine

AI Medical Technology: A Rising Leader, One Year Later

AI Medical Technology has been busy, with publications demonstrating its lead product’s potential in melanoma, ongoing fundraising and board appointments.

Rising Leaders Digital Health

Addex Gets Creative To Secure Funding And Its Future

Addex Therapeutics’ Tim Dyer has seen the company through 22 years of ups and downs. He has kept the company afloat, and recently did the same by spinning out a new company.

Leadership Strategy

Execs On The Move: March 2024

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Medical Device BioPharmaceutical

Helping Organizations Deliver On KPIs And Giving Staff A Voice

ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.

Rising Leaders Medical Device

South Korea Sees Pharma Leadership Transition

Leadership succession is proceeding within South Korean pharmaceutical corporations such as Daiichi Sankyo Korea, Astellas Pharma Korea, Kyowa Kirin Korea as well as MSD Korea.

Asia Pacific South Korea

Keys To Success: Maniacal Focus And Adaptive Readiness

With an engineer’s mind, Jason Park, CEO of Empress Therapeutics, has a unique take on problem solving for fundraising and the value of being a platform company focused on small molecules.

Rising Leaders Leadership

Bringing The Circular Economy Sharply Into Focus For Healthtechs

Addie MacGregor, at the Association of British HealthTech Industries, guides and advises an industry eager to comply but in search of direction, on matters of environmental sustainability for health care technology manufacturers.

Rising Leaders Commercial

Investing Is A People Business, Says LifeArc’s Clare Terlouw

Success in life sciences venture funding requires drive and speed, says In Vivo Rising Leader, Clare Terlouw. But there is more to it than that.

Rising Leaders VC Playbook

Moving Pharma Execs Out Of The Shadows Is Key To Building Public Trust

2024 Rising Leader, Jack O’Meara, says the industry must ‘promote personalities’ when building new biotech businesses to gain the trust of investors and the public. 

Rising Leaders Business Strategies

In Vivo's 2024 Rising Leaders At A Glance

Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.

Rising Leaders Leadership

In Vivo’s 2024 Rising Leaders

The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.

Rising Leaders Leadership
See All
UsernamePublicRestriction

Register